Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

C4 Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues31.145.833.221.419.4
            Revenue growth-32.1%37.9%55.3%10.4% 
Cost of goods sold0.00.00.00.00.0
Gross profit31.145.833.221.419.4
            Gross margin100.0%100.0%100.0%100.0%100.0%
Research and development117.894.778.448.128.6
General and administrative42.833.315.28.87.2
EBIT-129.5-82.1-60.4-35.5-16.4
            EBIT margin-416.6%-179.4%-182.1%-165.8%-84.6%
Pre-tax income-128.2-83.9-67.0-33.3-15.7
Income taxes0.00.0-0.60.80.0
            Tax rate0.0%0.0%0.9% 0.0%
Net income-128.2-83.9-66.3-34.1-15.7
            Net margin-412.2%-183.2%-199.8%-159.5%-81.1%
 
Diluted EPS($2.62)($1.82)($5.83)($24.86)($0.01)
Shares outstanding (diluted)48.946.011.41.41,293.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy